• HIV PrEP Guidelines

  • HIV pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV among adults and adolescents. The FDA has approved two effective and distinct co-formulated antiviral agents for the prevention of HIV acquisition in adults and adolescents.  Affinity Health Plan covers both of these antiviral preparations.

    The New York State HIV Clinical Guidelines Program has issued updated clinical guidelines regarding PrEP. The following elements of the updated guidelines will serve to make PrEP easier for individuals to use and easier for clinicians to prescribe and manage.

    These updated guidelines are available at https://www.hivguidelines.org/prep-for-prevention/.

    New York is currently pursuing a ground-breaking effort to end the AIDS epidemic by the end of 2020. For more about this effort, visit  https://www.health.ny.gov/diseases/aids/ending_the_epidemic/.